ReviewCancers2023

Toll-like Receptor Agonists Are Unlikely to Provide Benefits in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

Sainiteesh Maddineni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.